Boston Scientific (BSX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
Get Alerts BSX Hot Sheet
Price: $41.98 -1.66%
Financial Fact:
Net income (loss): 228M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Net income (loss): 228M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.86, $0.03 better than the analyst estimate of $0.83. Revenue for the quarter came in at $5.44 billion versus the consensus estimate of $5.37 billion.
GUIDANCE:
Boston Scientific sees FY2026 EPS of $3.28-$3.32, versus the consensus of $3.36.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Oppenheimer Holdings (OPY) Reports Q3 EPS of $1.81
- Dominion Energy (D) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share